UnitedHealth Group shares rose 3.87% on Wednesday before climbing another 1.17% in after-hours trading, according to Benzinga. The gains followed the announcement of a $2.21 quarterly dividend for September 23rd, payable to shareholders of record by September 15th. The Minnesota-based company’s stock is down about 53% over the past year, with a market capitalization of $246.17 billion. On Friday, the company agreed to sell over 160 healthcare facilities as part of a DOJ settlement related to its $3.3 billion Amedisys acquisition. The company faces challenges with a low P/E ratio of 11.77, a 3.25% dividend yield, and second-quarter earnings of $4.08 that missed estimates and fell from $6.80 last year. Revenue rose 13% to $111.62 billion but missed estimates, and 2025 earnings guidance of at least $16 per share is far below the $22.33 analyst consensus.
00:00It's Benzinga, bringing Wall Street to Main Street.
00:02UnitedHealth Group shares rose 3.87% on Wednesday before climbing another 1.17% in after-hours trading, according to Benzinga.
00:09Keynes filed the announcement of a $2.21 quarterly dividend for September 23rd, and able to share it as a record by September 15th.
00:16The Minnesota-based company's stock is down about 53% over the past year, with a market capitalization of $246.17 billion.
00:23On Friday, the company agreed to sell over 160 healthcare facilities as part of a DOG settlement related to its $3.3 billion Amidus acquisition.
00:32The company faces challenges with a low P-E ratio of 11.77, a 3.25% dividend yield, and second-quarter earnings of $4.08, and missed estimates that fell from $6.80 last year.
00:43Revenue rose 13% to $111.62 billion, but missed estimates in 2025 earnings guidance of at least $16 per share is far below the $22.33 analyst consensus.
